
--- Page 1 ---
 UID: EDF0AEC5-33E5-48EB-AD7A-C2F0C49C05F0 TCGA-LN-A7HW-01A-PR Redacted IRB APPROVED Clinical Case Report. ID O-3 8870h3 thud J C15.4 Informed Consent ytJ 1o/0/i3 I personally informed this patient that a specimen(s) would be collected to be used for research purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT FORM with the patient and answered any questions the patient had. The patient then signed the consent form as a free and voluntary act. A copy of this informed consent document will be retained at our institution. Name of Physician or Study Coordinator Signature Date Clinical Information GENERAL INFORMATION Date of Birth (mm/dd/yyyy) Height Marital Status Race Temperature SingleMarried Gender Weight  Divorced  Widow  Blood Pressure Heart Rate Male   Female Q3/7 HISTORY OF PRESENT ILLNESS Chief Complaints: ~Tuhe e SWalloWinq ) vo ctl ch cncge Symptoms: Fever ) "foitiouo Clinical Findings: Performance Scale (Karnofsky Score):  100 Asymptomatic  80-90 Symptomatic but Fully Ambulatory 60-70 Symptomatic, in bed less than 50% of day  40-50 Symptomatic, in bed more than 50% of day, but not bed ridden ...  20-30 Bed Ridden CURRENT MEDICATIONS Drug Dose Route Freguency Date (mm/dd/yyy) To 1 1 To 1 / To To To

--- Page 2 ---
PAST MEDICAL HISTORY Dlagnosis/Disease/Disorder/Infury Diagnosis Date Treatment Status OB/GYN HISTORY Menopausal Status Date of First Menses # of Pregnancies  Pre-menopausal  Peri-Menopausal Date of Last Menses # of Live Births  Post-menopausal Sirth Control:  Condom  Oral Contraceptive IUD  Hormone Replacement Therapy:  Other: SOCIAL HISTORY Environmental Hazards: Occupation: Smoking History TYPE Packs/day Duration When Quit Current Status DeTda) Li () (yrs)L wcth cs(h (y) YES ONO Alcohol Consumption Current Status TYPE Drinks/day Duration When Quit 2donls(day P YES ONO (yrs).Lscn[hSs4D (y) Drug Use U. TYPE Frequency Duration When Quit Current Status  yES NO (yrs) FAMILY MEDICAL HISTORY Relative Diagnosis Age of Diagnosis LAB DATA Result Test Result Date Test Date HIV Negative  Positive: CEA  Negative  Positive: Hep B Negative  Positive: CA 15-3   Negative  Positive: Hep C  Positive:  CA 19-9   Negative  Positive: Negative 1 AFP  Negative  Positive: PSA   Negative  Positive: Other: Other:  Negative  Positive:  Negative  Positive: B/T Cell Markers: 2

--- Page 3 ---
DIAGNOSTIC STUDIES Study Results Date Ultrasound X-Ray CT EndoscopyeA tisonuy was Joura in ce se>ophagu MRI Biopsy CLINICAL DIAGNOSIS  Preoperative Clinical Diagnosis. EQshageal cticeR Location of Suspected Involved'Lymph Nodes Location of Suspected Distant Metastasis Clinical Staging Date of Diagnosis TZ NO Mg Stage: II A-- Treatment Information SURGICAL TREATMENT Procedure Date of Procedure Peseitcr dl the. Primary Tumor Organ Detailed Location Size L= 8vpneFZes ZiinxR eicelle .thiea 3 x2 x/ cm Extension of Tumor Lymph Nodes Description Location of Lymph Nodes # of Lymph Nodes Palpable, Non-Dissected Lymph Nodes Dissected Lymph Nodes Distant Metastasis Organ  Detailed Location Size Surgical Staging T2 No M c Stage: NEOADJUVENT THERAPY (Chemo, Radiation, Immuno, Hormonal, or Molecular) Drug/Treatment Dose Route Frequency Date (mm/dd/yyyy) To To 1 To 1 1 To 1 / To. 3

--- Page 4 ---
Pathology Form Specimen Information Date: . Time: Collected by: Date:. Time: Preserved by: SPECIMEN TYPE (# of samples provided) Paraffin Block  Blood/Serum/Plasma  Slide Frozen Normal Diseased Normal Diseased Normal Diseased Normal Diseased 2 2 2 4 Time to LN2 Time to Formalin Time to LN2 min min min 13 PATHOLOGICAL DESCRIPTION Primary Tumor Size Extension of Tumor Distance to NAT Organ 6 3 x 2 x4 cmmidllle Mhird cm Aeems Lymph Nodes # Examined # Metastasized Location Distant Metastasis Detailed Location Size Organ Pathological Staging NO pT 2 Stage: I Notes: 4

--- Page 5 ---
IRS APPROVED Consolidated Pathology Diagnosis ID#: Cell Distribution + Structural Pattern Diffuse + 1. Streaming Mosaic  Storiform Necrosis Y Fibrosis Lymphocytic Infiltration Y Pallsading. Vascular Invasion Cystkc Degeneration Clusterized  Bleeding Alveolar Formation  Myxoid Change  Indian File XPsammoma/Calcification  Squamous Adenomatous +-  Sarcomatous +  Squamoid Cell Lymphomatous Glandular celf + Round Cell  Large Cell Spindle Cell Cell Stratification Fibroblast Small Cell  Keratin Secretion Osteoblast  RS Cell/RS Like Desmosome Intracyt. Vacuole Lipoblast Peart Inflam. Cell  Gland formation Myoblast Plasma Cell Cellular Differentiation: o Well  Moderate  Poor Nuclear Atypla: 0 1 II  Aniso Nucleosis III X Hyperchromatism Nucleolar Prominent X Multinucleated Giant Cell Mitotic Activity Nuclear Grade: x Final Pathology Report Comments: D1$87 br82 03407 546% Nsiewst 297 Date Director, Research Pathologye hw 8/3/3 INTEGRATED REPORT OF FINDINGS BY COLLABORATORS AND Criteria PATHOLOGISTS Diagnosis Discrepancy Primary Tumor Site Discrepancy HIPAA Discrepancy